carvedilol has been researched along with Hypertrophy in 2 studies
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, limited data exist regarding the effects of the beta-blocker (BB) carvedilol on arrhythmia and urologic outcomes in BPH patients." | 8.31 | Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients. ( Heo, JH; Im, SI; Kang, PM; Kim, BJ; Kim, HS; Kim, SJ; Kim, TS; Park, HS, 2023) |
| "Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values." | 5.33 | Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. ( Chang, H; Fang, WJ; Liou, JY; Shyu, KG; Wang, BW, 2005) |
| " However, limited data exist regarding the effects of the beta-blocker (BB) carvedilol on arrhythmia and urologic outcomes in BPH patients." | 4.31 | Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients. ( Heo, JH; Im, SI; Kang, PM; Kim, BJ; Kim, HS; Kim, SJ; Kim, TS; Park, HS, 2023) |
| "Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values." | 1.33 | Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. ( Chang, H; Fang, WJ; Liou, JY; Shyu, KG; Wang, BW, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SJ | 1 |
| Park, HS | 1 |
| Kang, PM | 1 |
| Kim, BJ | 1 |
| Kim, HS | 1 |
| Heo, JH | 1 |
| Kim, TS | 1 |
| Im, SI | 1 |
| Shyu, KG | 1 |
| Liou, JY | 1 |
| Wang, BW | 1 |
| Fang, WJ | 1 |
| Chang, H | 1 |
2 other studies available for carvedilol and Hypertrophy
| Article | Year |
|---|---|
Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carvedilol; Humans; Hypertrophy; Male; Prostate; | 2023 |
Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Aorta; Arteries; Blotting, Western; Body Weight; C | 2005 |